Reduce falls with treadmill training
- Trial ID
- NCT07058285
- Official Title
- Steps Against the Burden of Parkinson's Disease
- Goal
- Reduce falls with treadmill training
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Kiel
- Study Type
- INTERVENTIONAL
- Enrollment
- 42 participants
- Conditions
- Parkinson Disease, Fall
- Interventions
- Speed-dependent treadmill training (SDTT), SDTT+ anteroposterior perturbations
Summary For Families
The goal is to reduce falls and improve walking stability and adaptability in people with Parkinson's who have mild to moderate disease and noticeable gait problems. The approach uses speed-dependent treadmill training, where the belt speed responds to your stepping to build steadier, more adaptable gait, and some sessions add brief forward and backward perturbations to practice automatic recovery from trips and slips. This is a rehab therapy that complements medications rather than replacing them. The trial is seeking people diagnosed with Parkinson's by MDS criteria, Hoehn and Yahr stages I to III, with at least mild gait impairment on the MDS-UPDRS, who can give informed consent and walk at least one floor, and who do not have severe depression, major cognitive impairment, implanted deep brain stimulation, or other conditions that make unsupervised exercise unsafe.
Locations
- University of Kiel, Kiel, Germany
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Speed-dependent treadmill training (SDTT). The goal is to reduce falls and improve walking stability and adaptability in people with Parkinson's who have mild to moderate disease and noticeable gait problems. The approach uses speed-dependent treadmill training, where the belt speed responds to your stepping to build steadier, more adaptable gait, and some sessions add brief forward and backward perturbations to practice automatic recovery from trips and slips. This is a rehab therapy that complements medications rather than replacing them. The trial is seeking people diagnosed with Parkinson's by MDS criteria, Hoehn and Yahr stages I to III, with at least mild gait impairment on the MDS-UPDRS, who can give informed consent and walk at least one floor, and who do not have severe depression, major cognitive impairment, implanted deep brain stimulation, or other conditions that make unsupervised exercise unsafe.
- Who can participate?
- Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 8 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.